Annika Linde
#100,102
Most Influential Person Now
Swedish physician, virologist
Annika Linde's AcademicInfluence.com Rankings
Annika Lindebiology Degrees
Biology
#9413
World Rank
#12617
Historical Rank
Virology
#217
World Rank
#224
Historical Rank
Annika Lindephilosophy Degrees
Philosophy
#11351
World Rank
#15626
Historical Rank
Logic
#8167
World Rank
#10170
Historical Rank
Download Badge
Biology Philosophy
Why Is Annika Linde Influential?
(Suggest an Edit or Addition)According to Wikipedia, Gerda Annika Linde is a Swedish physician, virologist and retired civil servant. From 2005 to 2013 she served as State Epidemiologist at the Swedish Institute for Communicable Disease Control. Biography Linde was born in Skövde and grew up there. She was inspired by the novel Exodus by Leon Uris to study medicine. She enrolled at Gothenburg University in 1968, studying medicine and sociology, obtaining a medical degree in 1974. After her internship at Danderyd Hospital she went on to work as an infectious disease specialist at the presently defunct Roslagstull Hospital in Stockholm. In 1979 she started working at the virological department at the Swedish National Bacteriological Laboratory, and completed her PhD in Clinical Virology in 1987. In 1993 she became head of the Swedish influenza centre of the WHO and started working for Department of Virology at the Swedish Institute for Communicable Disease Control, where she in 2002 became department head. In 2005 she became head of the Department of Epidemiology and was in the same year appointed State Epidemiologist. She served in this role until her retirement in 2013, when she was succeeded by Anders Tegnell.
Annika Linde's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- A role for a new herpes virus (KSHV) in different forms of Kaposi's sarcoma (1995) (320)
- Epstein-Barr virus DNA in cerebrospinal fluid from patients with AIDS-related primary lymphoma of the central nervous system (1993) (306)
- Diagnosis of central nervous system complications in HIV-infected patients: cerebrospinal fluid analysis by the polymerase chain reaction. (1997) (240)
- Polymerase chain reaction on cerebrospinal fluid for diagnosis of virus-associated opportunistic diseases of the central nervous system in HIV-infected patients (1996) (216)
- High levels of human herpesvirus 6 DNA in peripheral blood leucocytes are correlated to platelet engraftment and disease in allogeneic stem cell transplant patients (2000) (189)
- Lymphotropic herpesviruses in allogeneic bone marrow transplantation. (1996) (189)
- Human herpesvirus 6 DNA in cerebrospinal fluid specimens from allogeneic bone marrow transplant patients: does it have clinical significance? (1999) (174)
- Efficacy and safety of vaccination of marrow transplant recipients with a live attenuated measles, mumps, and rubella vaccine. (1989) (152)
- Serum levels of lymphokines and soluble cellular receptors in primary Epstein-Barr virus infection and in patients with chronic fatigue syndrome. (1992) (148)
- Incidence and pathogenesis of clinical relapse after herpes simplex encephalitis in adults (2006) (142)
- Does viral interference affect spread of influenza? (2009) (136)
- Virus-specific immunoglobulin G subclasses in herpes simplex and varicella-zoster virus infections (1984) (113)
- Absence of seven human herpesviruses, including HHV‐6, by polymerase chain reaction in CSF and blood from patients with multiple sclerosis and optic neuritis (1997) (108)
- Rapid viral diagnosis of acute respiratory infections: comparison of enzyme-linked immunosorbent assay and the immunofluorescence technique for detection of viral antigens in nasopharyngeal secretions (1985) (105)
- Cardiac troponin I in feline hypertrophic cardiomyopathy. (2002) (104)
- Vaccination of patients with haematological malignancies with one or two doses of influenza vaccine: a randomised study (2005) (103)
- Viral Load of Human Herpesvirus 8 in Peripheral Blood of Human Immunodeficiency Virus-Infected Patients with Kaposi's Sarcoma (2001) (102)
- Does early EBV infection protect against IgE sensitization? (2005) (95)
- Case-Control Study on Concentrations of Organohalogen Compounds and Titers of Antibodies to Epstein-Barr Virus Antigens in the Etiology of Non-Hodgkin Lymphoma (2001) (92)
- Human Cytomegalovirus Strain-Dependent Changes in NK Cell Recognition of Infected Fibroblasts1 (2000) (89)
- Granulocyte-macrophage colony-stimulating factor as immunomodulating factor together with influenza vaccination in stem cell transplant patients. (2000) (88)
- Innate immunity and host defense peptides in veterinary medicine. (2008) (88)
- Circulating Epstein–Barr Virus in Children Living in Malaria‐Endemic Areas (2005) (87)
- Subclass reactivity to epstein‐barr virus capsid antigen in primary and reactivated EBV infections (1987) (83)
- Shedding of cytomegalovirus and herpesviruses 6, 7, and 8 in saliva of human immunodeficiency virus type 1-infected patients and healthy controls. (1998) (83)
- Cytomegalovirus viraemia and specific T‐helper cell responses as predictors of disease after allogeneic marrow transplantation (1993) (79)
- Varicella-zoster virus (VZV) DNA in cerebrospinal fluid of patients infected with human immunodeficiency virus: VZV disease of the central nervous system or subclinical reactivation of VZV infection? (1997) (78)
- Innate immunity and inflammation--New frontiers in comparative cardiovascular pathology. (2007) (77)
- IgG antibodies to human herpesvirus-6 in children and adults both in primary Epstein-Barr virus and cytomegalovirus infections (1988) (73)
- Sequence Variation within Three Important Cytomegalovirus Gene Regions in Isolates from Four Different Patient Populations (1998) (72)
- Specific diagnostic methods for herpesvirus infections of the central nervous system: a consensus review by the European Union Concerted Action on Virus Meningitis and Encephalitis. (1997) (70)
- Post-transplant lymphoproliferative disease and other Epstein-Barr virus diseases in allogeneic haematopoietic stem cell transplantation after introduction of monitoring of viral load by polymerase chain reaction (2007) (70)
- Reactivation of human herpesvirus 6 during pregnancy. (1999) (70)
- Identification of viral agents associated with diarrhea in young children during a winter season in Beijing, China (2005) (66)
- Transfer and persistence of viral antibody-producing cells in bone marrow transplantation. (1984) (64)
- Similar Humoral and Cellular Immunological Reactivities to Human Herpesvirus 6 in Patients with Multiple Sclerosis and Controls (1999) (64)
- Cytomegalovirus DNA detection of an immediate early protein gene with nested primer oligonucleotides. (1991) (63)
- Restricted IgG subclass responses to HTLV-III/LAV and to cytomegalovirus in patients with AIDS and lymphadenopathy syndrome. (1986) (61)
- Antigen detection: the method of choice in comparison with virus isolation and serology for laboratory diagnosis of herpes zoster in human immunodeficiency virus-infected patients (1997) (61)
- Herpes simplex virus infections of the central nervous system in human immunodeficiency virus-infected patients: clinical management by polymerase chain reaction assay of cerebrospinal fluid. (1998) (60)
- Detection of Epstein-Barr Virus, but not Human Herpesvirus 8, DNA in Cervical Secretions From Swedish Women by Real-Time Polymerase Chain Reaction (2001) (59)
- Early-life EBV infection protects against persistent IgE sensitization. (2010) (59)
- Development and evaluation of a flow-cytometric assay of specific cell-mediated immune response in activated whole blood for the detection of cell-mediated immunity against varicella-zoster virus. (2003) (57)
- Evaluation of enzyme-linked immunosorbent assays with two synthetic peptides of Epstein-Barr virus for diagnosis of infectious mononucleosis. (1990) (54)
- Seroprevalence of viral childhood infections in Eritrea. (2000) (53)
- An international external quality assessment of nucleic acid amplification of herpes simplex virus. (2003) (52)
- Changes in seroprevalence to four herpesviruses over 30 years in Swedish children aged 9-12 years. (2006) (52)
- The humoral response to live and inactivated influenza vaccines administered alone and in combination to young adults and elderly. (2002) (52)
- Preventive effect of IgG from EBV‐seropositive donors on the development of human lympho‐proliferative disease in SCID mice (1997) (52)
- Viral etiology of acute childhood encephalitis in Beijing diagnosed by analysis of single samples. (1996) (51)
- Effect of primary Epstein-Barr virus infection on human herpesvirus 6, cytomegalovirus, and measles virus immunoglobulin G titers (1990) (51)
- Concentrations of organochlorines related to titers to Epstein-Barr virus early antigen IgG as risk factors for hairy cell leukemia. (2000) (48)
- Detection of human herpesvirus 8 DNA in serum from blood donors with HHV‐8 antibodies indicates possible bloodborne virus transmission (2002) (48)
- Variations in the cytomegalovirus DNA polymerase and phosphotransferase genes in relation to foscarnet and ganciclovir sensitivity. (2001) (48)
- Ganciclovir is associated with low or undetectable Epstein-Barr virus DNA load in cerebrospinal fluid of patients with HIV-related primary central nervous system lymphoma. (2006) (48)
- Inhibition of human herpesvirus 6 replication by 9-[4-hydroxy-2-(hydroxymethyl)butyl]guanine (2HM-HBG) and other antiviral compounds (1990) (47)
- Human herpesvirus 6 infection inhibits specific lymphocyte proliferation responses and is related to lymphocytopenia after allogeneic stem cell transplantation (1999) (47)
- Evaluation of three commercial enzyme-linked immunosorbent assays and two latex agglutination assays for diagnosis of primary Epstein-Barr virus infection (1997) (47)
- Monitoring of herpes simplex virus DNA types 1 and 2 viral load in cerebrospinal fluid by real‐time PCR in patients with herpes simplex encephalitis (2009) (47)
- Pretransplant herpesvirus serology and acute graft-versus-host disease. (1988) (47)
- Human immunodeficiency virus type 1 and cytomegalovirus in saliva (1993) (46)
- Cytomegalovirus infection and development of allergic diseases in early childhood: interaction with EBV infection? (2004) (45)
- Ganciclovir therapy for cytomegalovirus (CMV) infection of the central nervous system in AIDS patients: monitoring by CMV DNA detection in cerebrospinal fluid. (1995) (42)
- Antibodies to human herpesvirus 8 latent and lytic antigens in blood donors and potential high‐risk groups in Sweden: Variable frequencies found in a multicenter serological study (2000) (41)
- Epstein-Barr virus DNA load in cerebrospinal fluid and plasma of patients with AIDS-related lymphoma (2011) (41)
- Infrequent detection of cytomegalovirus and Epstein-Barr virus DNA in synovial membrane of patients with rheumatoid arthritis. (1998) (41)
- Direct identification by PCR of EBV types and variants in clinical samples (1997) (40)
- Epstein‐Barr virus and cytomegalovirus are differentially associated with numbers of cytokine‐producing cells and early atopy (2009) (39)
- Diagnosis of Epstein-Barr virus-related diseases. (1996) (38)
- Pilot study on cardiac troponin I levels in dogs with pericardial effusion. (2006) (38)
- Acute "idiopathic" peripheral facial palsy: clinical, serological, and cerebrospinal fluid findings and effects of corticosteroids. (1993) (37)
- Upregulated local cytokine production in recurrent tonsillitis compared with tonsillar hypertrophy. (1995) (37)
- Epstein‐barr virus and cytomegalovirus in relation to testicular‐cancer risk: a nested case‐control study (1999) (37)
- Acute peripheral facial palsy: CSF findings and etiology (1991) (37)
- Sensitive analytic ELISAs for subclass herpes virus IgG. (1985) (35)
- Epstein-Barr virus DNA in serum after liver transplantation — surveillance of viral activity during treatment with different immunosuppressive agents (1996) (33)
- Herpesvirus Seropositivity in Childhood Associates with Decreased Monocyte-Induced NK Cell IFN-γ Production1 (2009) (33)
- Epstein-Barr virus (EBV) DNA in saliva and EBV serology of HIV-1-infected persons with and without hairy leukoplakia. (1995) (33)
- A new European perspective of influenza pandemic planning with a particular focus on the role of mammalian cell culture vaccines. (2005) (31)
- Intrathecal antibody production against viruses of the herpesvirus family in acute retinal necrosis syndrome. (1991) (31)
- Hodgkin's lymphoma, Epstein–Barr virus reactivation and fatal haemophagocytic syndrome (2004) (31)
- Human herpesvirus 6 infection and cytomegalovirus-specific lymphoproliferative responses in allogeneic stem cell transplant recipients (2002) (30)
- An enzyme-linked immunosorbent assay for IgG antibodies to human herpes virus 6. (1990) (30)
- IgG SUBCLASS DEFICIENCY AND CHRONIC FATIGUE SYNDROME (1988) (29)
- Involvement of aberrant p53 expression and human papillomavirus in carcinoma of the head, neck and esophagus. (1994) (29)
- Adipose tissue concentrations of dioxins and dibenzofurans, titers of antibodies to Epstein-Barr virus early antigen and the risk for non-Hodgkin lymphoma. (2001) (29)
- Lymphoproliferative responses to human herpesvirus‐6 variant A and variant B in healthy adults (1999) (28)
- Functional comparison of single- and double-stranded siRNAs in mammalian cells. (2004) (28)
- In vitro inhibition of SARS virus replication by human interferons (2004) (27)
- Echocardiography in the chinchilla. (2004) (27)
- IgG subclasses to subviral components. (1988) (27)
- Seroprevalence of human herpes virus 8 in different Eritrean population groups. (1999) (26)
- Cardiac Troponin I in Feline Hypertrophic Cardiomyopathy (2002) (26)
- Diagnosis of cytomegalovirus infections using polymerase chain reaction, virus isolation and serology. (1993) (26)
- Vaccination of autologous stem cell transplant recipients with live varicella vaccine: a pilot study (2003) (26)
- The importance of specific virus diagnosis and monitoring for antiviral treatment. (2001) (25)
- Human cytomegalovirus, human herpesvirus-6 and human herpesvirus-7 in neutropenic patients with fever of unknown origin. (2003) (25)
- Human herpesvirus 6 in cerebrospinal fluid of patients infected with HIV: frequency and clinical significance (1999) (25)
- Epstein-Barr virus infection is not associated with development of allergy in children (2003) (24)
- Respiratory Virus Infections in Stockholm During Seven Seasons: A Retrospective Study of Laboratory Diagnosis (2004) (24)
- Antibiotic prescriptions and laboratory-confirmed cases of Mycoplasma pneumoniae during the epidemic in Sweden in 2011. (2012) (23)
- Aberrant IgG subclass distribution to measles in healthy seropositive individuals, in patients with SSPE and in immunoglobulin‐deficient patients (1990) (23)
- No Evidence of Active Infection with Human Herpesvirus 6 (HHV-6) or HHV-8 in Chronic Fatigue Syndrome (2000) (23)
- Effective construction of DNA vaccines against variable influenza genes by homologous recombination. (2000) (22)
- Diagnosis of pulmonary infections in immunocompromised patients by fiber-optic bronchoscopy with bronchoalveolar lavage and serology. (1996) (22)
- Antiviral IgM and IgG subclasses in varicella zoster associated neurological syndromes. (1989) (22)
- Diagnosis of cytomegalovirus in bronchoalveolar lavage by polymerase chain reaction, in comparison with virus isolation and detection of viral antigen. (1993) (22)
- HHV‐6 A‐ or B‐specific P41 antigens do not reveal virus variant‐specific IgG or IgM responses in human serum (2002) (21)
- IgG‐SUBCLASS‐SPECIFIC CMV REACTIVITY IN BONE MARROW TRANSPLANT RECIPIENTS (1984) (21)
- DNA vaccination of ferrets with chimeric influenza A virus hemagglutinin (H3) genes. (2002) (20)
- Screening for aortic stenosis in the Boxer: Auscultatory, ECG, blood pressure and Doppler echocardiographic findings. (2006) (20)
- Combination ELISAs for antiviral antibodies in CSF and serum in patients with neurological symptoms and in healthy controls. (1988) (19)
- Pretransplant herpes virus serology and chronic graft-versus-host disease. (1989) (19)
- Antiviral therapy in children with hydroa vacciniforme. (2009) (19)
- HUMAN HERPESVIRUS-6 AND CROSS-REACTIVITY WITH OTHER HERPESVIRUSES (1989) (18)
- Polymerase chain reaction and in situ hybridization of Epstein-Barr virus in liver biopsy specimens facilitate the diagnosis of EBV hepatitis after liver transplantation (1998) (18)
- The Eurocine L3 adjuvants with subunit influenza antigens induce protective immunity in mice after intranasal vaccination. (2010) (17)
- A novel varicella-zoster virus gE mutation discovered in two Swedish isolates. (2006) (17)
- Soluble CD23 in cerebrospinal fluid: a marker of AIDS-related non-Hodgkin's lymphoma in the brain (2001) (17)
- OKT3 and ganciclovir treatments are possibly related to the presence of Epstein–Barr virus in serum after liver transplantation (2005) (17)
- Elevated antibody levels to Epstein-Bbarr virus antigens in patients with hairy cell leukemia compared to controls in relation to exposure to pesticides, organic solvents, animals, and exhausts. (1999) (17)
- Postpartum activation of autoimmunity: transient increase of total IgG levels in normal women and in women with autoimmune thyroiditis. (1987) (16)
- Interferon γ (IFN-γ) Deficiency in Generalized Epstein-Barr Virus Infection with Interstitial Lymphoid and Granulomatous Pneumonia, Focal Cerebral Lesions, and Genital Ulcers: Remission Following IFN-γ Substitution Therapy (1999) (15)
- Clinical Relevance of Cathelicidin in Infectious Disease (2013) (15)
- Effectiveness of ganciclovir against human herpesvirus-6 excreted in saliva in stem cell transplant recipients (2007) (14)
- Solid phase ELISA for determination of the virus dose dependent sensitivity of human cytomegalovirus to antiviral drugs in vitro. (1998) (14)
- Herpesvirus infections and allergic sensitization in children of families with anthroposophic and non‐anthroposophic lifestyle – the ALADDIN birth cohort (2013) (14)
- Detection of respiratory viruses in nasopharyngeal secretions with immunofluorescence technique for multiplex screening-an evaluation of the Chemicon assay. (1996) (13)
- Immunogenicity and Reactogenicity of a Single Dose of Live Attenuated Varicella Vaccine and a Booster Dose of Measles–Mumps–Rubella Vaccine Given Concomitantly at 12 years of Age (2003) (13)
- Cross-talk between human herpesvirus 8 and the transactivator protein in the pathogenesis of Kaposi's sarcoma in HIV-infected patients. (2003) (13)
- Epstein-Barr virus induced thrombocytopenia treated with intravenous acyclovir and immunoglobulin. (1989) (12)
- Specific T and B cell immunity to measles after allogeneic and autologous bone marrow transplantation. (1995) (12)
- Diagnosis of cytomegalovirus infection of the nervous system in AIDS by polymerase chain reaction analysis of cerebrospinal fluid. (1995) (12)
- Th1 and Th2 cytokine responses after measles antigen stimulation in vitro in bone marrow transplant patients: response to measles vaccination (1997) (11)
- Influence of the specific T cell response on seroconversion after measles vaccination in autologous bone marrow transplant patients. (1996) (11)
- Serum HHV8 DNA and Tat antibodies in Kaposi's sarcoma patients with and without HIV-1 infection. (2003) (11)
- IgG antibodies to human herpesvirus-6 in children and adults and in primary Epstein-Barr virus infections and cytomegalovirus infections [corrected]. (1988) (11)
- Natural History of Innate Host Defense Peptides (2009) (11)
- Herpesvirus serology, aberrant specific immunoglobulin G2 and G3 subclass patterns and Gm allotypes in individuals with low levels of IgG3 (1992) (11)
- Immunoglobulin G subclasses and lymphocyte stimulatory responses to cytomegalovirus in transplant patients with primary cytomegalovirus infections (1992) (11)
- Rat Cardiomyocytes Express a Classical Epithelial Beta-Defensin (2008) (11)
- Sequence analysis of UL54 and UL97 genes and evaluation of antiviral susceptibility of human cytomegalovirus isolates obtained from kidney allograft recipients before and after treatment (2001) (10)
- Presence of autologous neutralizing antibodies against cytomegalovirus (CMV) in serum of human immunodeficiency virus type 1-infected patients shedding CMV in saliva. (1994) (9)
- Characterization of Oral Microbiota in Cats: Novel Insights on the Potential Role of Fungi in Feline Chronic Gingivostomatitis (2021) (8)
- Definition of a Divergent Epitope That Allows Differential Detection of Early Protein p41 from Human Herpesvirus 6 Variants A and B (2001) (8)
- Assessment of bacterial and fungal populations in urine from clinically healthy dogs using next‐generation sequencing (2021) (8)
- Synthetic peptides deduced from the amino acid sequence of Epstein‐Barr virus nuclear antigen 6 (EBNA 6): Antigenic properties, production of monoreactive reagents, and analysis of antibody responses in man (1995) (8)
- Difference in immune response in vaccinated and unvaccinated Swedish individuals after the 2009 influenza pandemic (2014) (7)
- Growth phenotypes of cytomegalovirus isolates do not correlate with glycoprotein B, major immediate early genotypes or antiviral sensitivity (2000) (7)
- Interferon gamma (IFN-gamma) deficiency in generalized Epstein-Barr virus infection with interstitial lymphoid and granulomatous pneumonia, focal cerebral lesions, and genital ulcers: remission following IFN-gamma substitution therapy. (1999) (7)
- T and B cell responses to cytomegalovirus antigens in healthy blood donors and bone marrow transplant recipients. (1993) (7)
- Toll-like receptor (TLR) 2 and TLR4 gene expression in canine heart (2007) (6)
- Multiple viral infections in HIV-infected children with chronically-evolving hepatitis. (1993) (5)
- IgG subclass distribution of antiviral antibodies in common variable immunodeficiency: effect of substitution therapy. (1988) (4)
- Antibody response to cytomegalovirus: A comparison between adult patients with neurological disease and uncomplicated infection (1981) (4)
- Surface features of human natural killer cells and antibody-dependent cytotoxic cells. (1985) (3)
- Tumor-specific antibodies in sera from patients with squamous cell carcinoma of the uterine cervix (1981) (3)
- Diagnosis of Virus‐associated Opportunistic Diseases of the Central Nervous System in Patients with HIV Infection by Polymerase Chain Reaction on Cerebrospinal Fluid (1994) (3)
- Monitoring EBV DNA in saliva for early diagnosis of EBV reactivation in solid tumour patients after allogeneic haematopoietic SCT (2009) (3)
- Specific IgG subclass reactivity in herpes simplex encephalitis (1988) (3)
- Correlation between cytomegalovirus and toxoplasma gondii serology and lymphocyte phenotypes in peripheral blood and cord blood. (1989) (2)
- Virological and clinical characteristics of human herpesvirus 6. (1991) (2)
- Intrafamilial transmission of symptomatic Epstein-Barr virus infection among six adult members of one family. (1990) (2)
- Detection of Human Papillomavirus, Epstein Barr Virus and Elevated or Mutant P53 Expression in Squamous Cell Carcinoma of the Head and Neck (1994) (2)
- Interventional Treatment of Pericardial Effusion (2010) (2)
- Annika with Kaposi ' s Sarcoma Immunodeficiency Virus-Infected Patients Peripheral Blood of Human Viral Load of Human Herpesvirus 8 in (2001) (2)
- IgG subclass responses to herpesvirus infections after bone marrow transplantation (1987) (1)
- Cardiac beta-defensins upregulate with a high fat diet and influence monocyte migration * (2013) (1)
- Immunoglobulin G abnormalities in HIV-1 infected individuals with lymphoma. (1998) (1)
- Epstein‐Barr virus DNA in serum after liver transplantation ‐ surveillance of viral activity during treatment with different immunosuppressive agents (1996) (1)
- IgG subclass responses to Bordetella pertussis filamentous haemagglutinin and pertussis toxin in whooping cough (1989) (1)
- Homozygous Deletion of the Immunoglobulin Cγ1 Gene (1988) (1)
- Subsets of T-cells and in vitro cytokine production after measles and varicellae-zoster virus antigen stimulation in allogeneic BMT patients. (1999) (1)
- Reactivation of Latent Epstein Barr Virus Infection Induces Remission of Splenic Lymphoma with Villous Lymphocytes (2005) (1)
- Virus reactivations and serology patterns following first-line therapy with alemtuzumab or fludarabine-based combination therapy in patients with chronic lymphocytic leukemia (2011) (1)
- Specific in vitro IgG subclass synthesis and lymphocyte proliferation responses in herpes virus encephalitis (1990) (1)
- Species-Spanning Echocardiography: Cardiovascular Insights from Across the Animal Kingdom (2020) (1)
- HHV8 AND OTHER HERPES VIRUS IN BIOPSIES OF AIDS RELATED AND ENDEMIC KAPOSI'S SARCOMA (KS) AND MALIGNANT LYMPHOMA: 33 (1997) (1)
- Transmission of human herpesvirus 6 (HHV-6) from mother to infant during pregnancy and/or delivery. Reactivation of HHV-6 during pregnancy. • 1310 (1997) (0)
- Concentrations ofOrganochlorines Related toTiters toEpstein-Barr Virus Early Antigen lgGasRiskFactors forHairy Cell Leukemia (2000) (0)
- Changes in NK Cell Recognition of Infected Human Cytomegalovirus Strain-Dependent (2000) (0)
- REPLY TO THE LETTER OF A. LOPEZ-NAVIDAD AND P. DOMINGO (1990) (0)
- Comparative studies on cardiac innate immunity (2008) (0)
- Polymerase chain reaction and in situ hybridization of Epstein‐Barr virus in liver biopsy specimens facilitate the diagnosis of EBV hepatitis after liver transplantation (1998) (0)
- [Specific immune response to vaccination with an inactivated flue vaccine depending on prevaccine status and age of the person vaccinated]. (2000) (0)
- WAHREN IgGl IgG 2 IgG 3 IgG 4 FrFh lrsmi anti HSV in patients with primary HSV nhHrm (0)
- Rapid determination of antiviral sensitivity of human cytomegalovirus (1995) (0)
- Inhibition ofHumanHerpesvirus 6Replication by9-(4-Hydroxy-2- (Hydroxymethyl)Butyl)Guanine (2HM-HBG)and OtherAntiviral Compounds (1990) (0)
- Applications for Peptides Found with Solid Phase Synthesis (1992) (0)
- Specific immune response to vaccination with inactivated influenza vaccine in vaccinees of different age with different prevaccinal status. (2000) (0)
- [Epstein-Barr virus infection--clinical aspects and diagnosis]. (1990) (0)
- Cardiac Innate Immunity (2008) (0)
- Viral infections and IgE sensitisation : CMV seropositivity in early life is associated with reduced numbers of IL-4-producing cells (2006) (0)
- Virus Reactivation Profile as Assessed by PCR and Serology Pattern Following First-Line Alemtuzumab (Anti-CD52 Monoclonal Antibody, Campath®) Therapy in Patients with B-CLL. (2004) (0)
- NK Cell IFN- Monocyte-Induced Associates with Decreased Herpesvirus Seropositivity in Childhood (2013) (0)
- [Epstein-Barr virus infections--clinical characteristics and diagnosis]. (1989) (0)
This paper list is powered by the following services:
Other Resources About Annika Linde
What Schools Are Affiliated With Annika Linde?
Annika Linde is affiliated with the following schools:
